06.02.15
MeadWestvaco announced a licensing agreement with Burgopak Ltd. MWV Healthcare will market Burgopak’s award-winning medication adherence packaging, serving the pharmaceutical and animal health markets in the U.S.
Patient medication adherence is a globally recognized challenge, with an estimated 50% of patients not taking their medication as prescribed. Collaborative action to address this challenge is growing rapidly across diverse corners of the healthcare sector, including within the pharmaceutical industry. Burgopak’s adherence-enhancing package has won 16 awards.
“This is a natural partnership of two businesses that have made a clear strategic commitment to improving medication adherence through packaging,” said John Grinnell, VP and managing director, MWV Healthcare, Secondary and Adherence. “The market for adherence packaging is growing as a result of the proven, positive impact it has on patients’ medication taking behavior. This agreement with Burgopak enhances MWV’s suite of adherence solutions.”
Similar to MWV’s suite of solutions, Burgopak’s package increases adherence through improved communication and patient engagement. A calendar feature can be incorporated into the design, and the package also keeps the patient information leaflet and medication connected at all times. Its tray-based carrier makes it ideal for use with blister materials, such as cold form foil, that are less suitable for other adherence packaging formats.
Patient medication adherence is a globally recognized challenge, with an estimated 50% of patients not taking their medication as prescribed. Collaborative action to address this challenge is growing rapidly across diverse corners of the healthcare sector, including within the pharmaceutical industry. Burgopak’s adherence-enhancing package has won 16 awards.
“This is a natural partnership of two businesses that have made a clear strategic commitment to improving medication adherence through packaging,” said John Grinnell, VP and managing director, MWV Healthcare, Secondary and Adherence. “The market for adherence packaging is growing as a result of the proven, positive impact it has on patients’ medication taking behavior. This agreement with Burgopak enhances MWV’s suite of adherence solutions.”
Similar to MWV’s suite of solutions, Burgopak’s package increases adherence through improved communication and patient engagement. A calendar feature can be incorporated into the design, and the package also keeps the patient information leaflet and medication connected at all times. Its tray-based carrier makes it ideal for use with blister materials, such as cold form foil, that are less suitable for other adherence packaging formats.